Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-000684
Filing Date
2017-02-15
Accepted
2017-02-15 15:09:34
Documents
80
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2230899z10-k.htm 10-K 1754631
2 EX-10.41 a2230899zex-10_41.htm EX-10.41 112798
3 EX-10.42 a2230899zex-10_42.htm EX-10.42 707840
4 EX-10.43 a2230899zex-10_43.htm EX-10.43 92987
5 EX-23.1 a2230899zex-23_1.htm EX-23.1 3035
6 EX-31.1 a2230899zex-31_1.htm EX-31.1 7798
7 EX-31.2 a2230899zex-31_2.htm EX-31.2 7786
8 EX-32.1 a2230899zex-32_1.htm EX-32.1 4574
9 EX-32.2 a2230899zex-32_2.htm EX-32.2 4564
16 G583820.JPG g583820.jpg GRAPHIC 44537
  Complete submission text file 0001047469-17-000684.txt   11866235

Data Files

Seq Description Document Type Size
10 EX-101.INS jagx-20161231.xml EX-101.INS 2539200
11 EX-101.SCH jagx-20161231.xsd EX-101.SCH 89754
12 EX-101.CAL jagx-20161231_cal.xml EX-101.CAL 79402
13 EX-101.DEF jagx-20161231_def.xml EX-101.DEF 385768
14 EX-101.LAB jagx-20161231_lab.xml EX-101.LAB 760636
15 EX-101.PRE jagx-20161231_pre.xml EX-101.PRE 597719
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 17614341
SIC: 2834 Pharmaceutical Preparations